About
Reagents for RNA interference
Areas of Focus
Categories
Non-Pharmaceutical
Clinical Trials (7)
View allTotal Trials
7
As Lead Sponsor
7
As Collaborator
0
Total Enrollment
930
By Phase
PHASE3: 1PHASE2: 3PHASE1: 2PHASE1/PHASE2: 1
By Status
COMPLETED: 7
Clinical Trials Pipeline7 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
Today
Hover over trial bars to see details
Recent Trials
NCT02560948Lead Sponsor
Clinical Efficacy and Safety of a Subcutaneous Immunotherapy With gpASIT+™ in Patients With Grass Pollen-induced Allergic Rhinoconjunctivitis
PHASE3Completed
554 participants
Started: Dec 31, 2015 · Completed: Aug 31, 2016
NCT02156791Lead Sponsor
Safety, Clinical Tolerability and Immunogenicity of Increasing Doses of gpASIT+TM
PHASE2Completed
61 participants
Started: Aug 31, 2013 · Completed: Dec 31, 2013
NCT01506375Lead Sponsor
Safety of gpASIT+TM Subcutaneously Administered to Hay Fever Patients With or Without Immunoregulating Adjuvant
PHASE2Completed
24 participants
Started: Nov 30, 2011 · Completed: Apr 30, 2013
NCT01308021Lead Sponsor
Clinical Efficacy and Safety of gpASIT+TM to Treat Seasonal Allergic Rhinoconjunctivitis
PHASE2Completed
202 participants
Started: Dec 31, 2010 · Completed: Dec 31, 2011
NCT01111279Lead Sponsor
Clinical Safety and Tolerability Study of gpASIT+TM and gpASIT+TM/Immunoregulating Adjuvant to Treat Seasonal Grass Pollen Rhinoconjunctivitis
PHASE1Completed
27 participants
Started: Mar 31, 2010 · Completed: Nov 30, 2010
Locations (1)
Headquarters
Planegg-Martinsried, Germany
Map
Loading map...